New study aims to improve long-term treatment for patients with bipolar disorder
Tuesday, May 24, 2011 - 14:00
in Health & Medicine
Patients with bipolar disorder may be eligible for a new clinical research study comparing two medications -- quetiapine (Seroquel), a widely prescribed second-generation antipsychotic mood-stabilizing medication, and lithium, the gold-standard mood stabilizer.